Dimitris Tousoulis

Prof. Dimitris Tousoulis

1st Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
Alexios S AntonopoulosAlexios S Antonopoulos
Alexios S Antonopoulos
FSFabio Sanna
Fabio Sanna
NSNikant Sabharwal
Nikant Sabharwal
STSheena Thomas
Sheena Thomas
EOEvangelos K. Oikonomou
Evangelos K. Oikonomou
CACharalambos Antoniades
Charalambos Antoniades
Adipocyte size and lipid content in perivascular adipose tissue are inversely associated with coronary inflammation and atherosclerotic plaque burden in human patients.

1 January 2012 in Current Vascular Pharmacology
Verified
Journal Article
Closed access
PDF file
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis
AKAnna-Maria Kampoli
Anna-Maria Kampoli
Nikolaos PapageorgiouNikolaos Papageorgiou
Nikolaos Papageorgiou
CSChristodoulos Stefanadis
Christodoulos Stefanadis
The vascular endothelium is a monolayer of cells between the vessel lumen and the vascular smooth muscle cells. Nitric oxide (NO) is a soluble gas continuously synthesized from the amino acid L-arginine in endothelial cells by the constitutive calcium-calmodulin-dependent enzyme nitric oxide synthase (NOS). This substance has a wide range of biological properties that maintain vascular homeostasis, including modulation of vascular dilator tone, regulation of local cell growth, and protection of the vessel from injurious consequences of platelets and cells circulating in blood, playing in this way a crucial role in the normal endothelial function. A growing list of conditions, including those commonly associated as risk factors for atherosclerosis such as hypertension, hypercholesterolemia, smoking, diabetes mellitus and heart failure are associated with diminished release of nitric oxide into the arterial wall either because of impaired synthesis or excessive oxidative degradation. The decreased production of NO in these pathological states causes serious problems in endothelial equilibrium and that is the reason why numerous therapies have been investigated to assess the possibility of reversing endothelial dysfunction by enhancing the release of nitric oxide from the endothelium. In the present review we will discuss the important role of nitric oxide in physiological endothelium and we will pinpoint the significance of this molecule in pathological states altering the endothelial function.

6 July 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
PTPanagiotis Theofilis
Panagiotis Theofilis
Marios SagrisMarios Sagris
Marios Sagris
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
Alexios S AntonopoulosAlexios S Antonopoulos
Alexios S Antonopoulos
GSGerasimos Siasos
Gerasimos Siasos
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis
Maintenance of endothelial cell integrity is an important component of human health and disease since the endothelium can perform various functions including regulation of vascular tone, control of hemostasis and thrombosis, cellular adhesion, smooth muscle cell proliferation, and vascular inflammation. Endothelial dysfunction is encompassed by complex pathophysiology that is based on endothelial nitric oxide synthase uncoupling and endothelial activation following stimulation from various inflammatory mediators (molecular patterns, oxidized lipoproteins, cytokines). The downstream signaling via nuclear factor-κB leads to overexpression of adhesion molecules, selectins, and chemokines that facilitate leukocyte adhesion, rolling, and transmigration to the subendothelial space. Moreover, oscillatory shear stress leads to pro-inflammatory endothelial activation with increased monocyte adhesion and endothelial cell apoptosis, an effect that is dependent on multiple pathways and flow-sensitive microRNA regulation. Moreover, the role of neutrophil extracellular traps and NLRP3 inflammasome as inflammatory mechanisms contributing to endothelial dysfunction has recently been unveiled and is under further investigation. Consequently, and following their activation, injured endothelial cells release inflammatory mediators and enter a pro-thrombotic state through activation of coagulation pathways, downregulation of thrombomodulin, and an increase in platelet adhesion and aggregation owing to the action of von-Willebrand factor, ultimately promoting atherosclerosis progression.

Verified
Journal Article
Open access
PDF file
Marios SagrisMarios Sagris
Marios Sagris
EVemmanouil vardas
emmanouil vardas
PTPanagiotis Theofilis
Panagiotis Theofilis
Alexios S AntonopoulosAlexios S Antonopoulos
Alexios S Antonopoulos
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis
Atrial fibrillation (AF) is the most frequent arrhythmia managed in clinical practice, and it is linked to an increased risk of death, stroke, and peripheral embolism. The Global Burden of Disease shows that the estimated prevalence of AF is up to 33.5 million patients. So far, successful therapeutic techniques have been implemented, with a high health-care cost burden. As a result, identifying modifiable risk factors for AF and suitable preventive measures may play a significant role in enhancing community health and lowering health-care system expenditures. Several mechanisms, including electrical and structural remodeling of atrial tissue, have been proposed to contribute to the development of AF. This review article discusses the predisposing factors in AF including the different pathogenic mechanisms, sedentary lifestyle, and dietary habits, as well as the potential genetic burden.

2 February 2016 in European Heart Journal
Verified
Journal Article
Open access
PDF file
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
EEEvangelos K. Economou
Evangelos K. Economou
FCFilippo Crea
Filippo Crea
JKJuan Carlos Kaski
Juan Carlos Kaski
The notion of atherosclerosis as a chronic inflammatory disease has intensified research on the role of cytokines and the way these molecules act and interact to initiate and sustain inflammation in the microenvironment of an atherosclerotic plaque. Cytokines are expressed by all types of cells involved in the pathogenesis of atherosclerosis, act on a variety of targets exerting multiple effects, and are largely responsible for the crosstalk among endothelial, smooth muscle cells, leucocytes, and other vascular residing cells. It is now understood that widely used drugs such as statins, aspirin, methotrexate, and colchicine act in an immunomodulatory way that may beneficially affect atherogenesis and/or cardiovascular disease progression. Moreover, advancement in pharmaceutical design has enabled the production of highly specific antibodies against key molecules involved in the perpetuation of the inflammatory cascade, raising hope for advances in the treatment of atherosclerosis. This review describes the actions and effects of these agents, their potential clinical significance, and future prospects.

1 August 2013 in JACC
Verified
Journal Article
Closed access
Dimitris TousoulisDimitris Tousoulis
Dimitris Tousoulis
Nikolaos PapageorgiouNikolaos Papageorgiou
Nikolaos Papageorgiou
EAEmmanuel Androulakis
Emmanuel Androulakis
GSGerasimos Siasos
Gerasimos Siasos
George LatsiosGeorge Latsios
George Latsios
CSChristodoulos Stefanadis
Christodoulos Stefanadis